跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SR-717
首页
药物
SR-717
SR-717
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of SR-717 agonist as novel coronavirus recombinant protein vaccine adjuvant
申请人: INST OF MILITARY VETERINARY MEDICINE ACADEMY OF MILITARY SCIENCES
优先权: 2022
CN
一种STING激动剂ST-71及其合成方法和应用
申请人: 河南牧业经济学院
优先权: 2023
CN
搭乘中性粒细胞靶向递送纳米颗粒及其制备方法和应用
申请人: 山东大学
优先权: 2023
CN
Application of SR-717 in preparation of medicine for preventing or treating intestinal radiation injury
申请人: SECOND MILITARY MEDICAL UNIV
优先权: 2024
CN
Application of swine STING molecular agonist SR-717 in preparation of pseudorabies virus infection resisting medicine
申请人: UNIV ANHUI AGRICULTURAL
优先权: 2025
CN
Photo-immune nano-particles as well as preparation method and application thereof
申请人: UNIV QINGDAO
优先权: 2025
CN
药物
反馈